VOLITIONRX LTD Mediaroom - PR Newswire APAC

VolitionRx Limited Announces Second Quarter 2021 Financial Results and Business Update

* Strong balance sheet with approximately $27.9 million in cash and cash equivalents * Strength...

2021-08-12 04:10 23919

VolitionRx Limited Schedules Second Quarter 2021 Earnings Conference Call and Business Update

AUSTIN, Texas, Aug. 4, 2021 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") t...

2021-08-04 20:15 39756

Volition's Nu.Q® NETs Assay Demonstrates Promising Results in COVID-19 Risk Stratification and Disease Monitoring

AUSTIN, Texas, July 22, 2021 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"),...

2021-07-22 20:00 10708

Volition's Nu.Q® NETs Assay Demonstrates Promising Results in COVID-19 Risk Stratification and Disease Monitoring

VolitionRx Limited Announces First Quarter 2021 Financial Results and Business Update

* Secured strongest-ever balance sheet with approximately $33.1 million in cash * Strengthened ...

2021-05-12 04:10 5060

VolitionRx Limited Schedules First Quarter 2021 Earnings Conference Call and Business Update

AUSTIN, Texas, May 6, 2021 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") to...

2021-05-06 20:15 2773

VolitionRx Limited Announces Publication of Significant Nu.Q® Capture Mass Spectrometry Paper

AUSTIN, Texas, March 31, 2021 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition")...

2021-03-31 20:30 1159

VolitionRx Limited Appoints Dr. Tom Butera DVM as Chief Executive Officer for Volition Veterinary Subsidiary

AUSTIN, Texas, March 30, 2021 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition")...

2021-03-30 20:30 2122

VolitionRx Limited Appoints Two New Directors

AUSTIN, Texas, March 29, 2021 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition")...

2021-03-30 04:10 2626

New Data Demonstrates Nu.Q® is Effective in Monitoring Treatment of Sepsis

AUSTIN, Texas, March 17, 2021 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition")...

2021-03-17 20:00 4736

VolitionRx Limited Schedules Full Fiscal Year 2020 Earnings Conference Call and Business Update

AUSTIN, Texas, March 16, 2021 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition")...

2021-03-16 20:30 4612

VolitionRx Limited to Present at Conferences in March 2021

AUSTIN, Texas, March 8, 2021 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") ...

2021-03-09 05:15 5272

VolitionRx Limited Announces Closing of $20 Million Underwritten Public Offering of Common Stock

AUSTIN, Texas, Feb. 12, 2021 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"),...

2021-02-12 22:25 11018

VolitionRx Limited Announces Pricing of $20 Million Underwritten Public Offering of Common Stock

AUSTIN, Texas, Feb. 10, 2021 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"),...

2021-02-10 22:18 8833

VolitionRx Provides a Business Update and Appoints Key Officers to Drive Commercialization Efforts

AUSTIN, Texas, Feb. 2, 2021 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") t...

2021-02-02 20:45 5868

VolitionRx Limited Opens its New Manufacturing Facility in Belgium

AUSTIN, Texas, Jan. 25, 2021 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") ...

2021-01-25 21:45 7522

VolitionRx Limited Awarded an Additional $4 Million in Non-Dilutive Funding

AUSTIN, Texas, Jan. 6, 2021 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") t...

2021-01-06 21:25 8846

VolitionRx Limited Appoints Dr. Tom Butera DVM to Board of Directors

AUSTIN, Texas, Dec. 3, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), ...

2020-12-03 21:30 9307

Volition Launches Nu.Q™ Vet Cancer Screening Test in the U.S.

AUSTIN, Texas, Dec. 1, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), ...

2020-12-01 21:45 8641

VolitionRx Limited to Present COVID-19 Data at MEDICA 2020

AUSTIN, Nov. 19, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a mult...

2020-11-19 20:00 6790

VolitionRx Limited to Present COVID-19 Data at MEDICA 2020

Volition Veterinary Presents Expert Report Ahead of First Product Launch

* A Look to the Future of Cancer Diagnostics compiles insight from four veterinary cancer experts...

2020-11-10 21:00 5677

Latest News